GSK plc (GSK)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Income statement
Currency in GBP. All numbers in thousandsBreakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
29,334,000
29,324,000
34,114,000
34,099,000
33,754,000
Cost of revenue
8,536,000
9,554,000
11,603,000
11,704,000
11,863,000
Gross profit
20,798,000
19,770,000
22,511,000
22,395,000
21,891,000
Operating expenses
Research development
5,744,000
5,488,000
5,278,000
5,098,000
4,568,000
Selling general and administrative
8,905,000
8,372,000
10,975,000
11,456,000
11,402,000
Total operating expenses
13,220,000
13,337,000
16,310,000
14,612,000
14,930,000
Operating income or loss
7,578,000
6,433,000
6,201,000
7,783,000
6,961,000
Interest expense
805,000
879,000
784,000
892,000
912,000
Income before tax
6,532,000
5,628,000
5,442,000
6,968,000
6,221,000
Income tax expense
752,000
707,000
346,000
580,000
953,000
Income from continuing operations
5,780,000
4,921,000
5,096,000
6,388,000
5,268,000
Net income
15,430,000
14,956,000
4,385,000
5,749,000
4,645,000
Net income available to common shareholders
15,430,000
14,956,000
4,385,000
5,749,000
4,645,000
Basic EPS
-
7.43
2.19
2.89
2.35
Diluted EPS
-
7.32
2.16
2.85
2.31
Basic average shares
-
2,013,000
2,001,500
1,990,500
1,978,800
Diluted average shares
-
2,042,000
2,026,000
2,015,000
2,006,400
© 2023 Yahoo. All rights reserved.
